Press release
Global Head And Neck Squamous Cell Carcinoma Market Projected to Surpass $2.81 Billion by 2029 with 9% Annual Growth
Head And Neck Squamous Cell Carcinoma Market Size
The market size of head and neck squamous cell carcinoma has seen substantial growth in the prior years. The projected growth is from $1.81 billion in 2024 to $1.98 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this growth during the historical span include heightened awareness and screening, expansion of combination therapies, advancements in healthcare infrastructure, increased healthcare expenditure, and an escalating incidence of head and neck squamous cell carcinoma.
The market size for head and neck squamous cell carcinoma is predicted to witness robust growth in the upcoming years. The market is expected to reach a valuation of $2.81 billion by 2029 at a compound annual growth rate (CAGR) of 9.2%. The projected growth during this period can be linked to increasing usage of tobacco, an aging population, supportive government policies, a rise in cancer cases, and an uptick in alcohol consumption. The future forecast period is likely to observe major trends such as the adoption of targeted therapies, investments in research and development, incorporation of immunotherapy, progression in technology, and advancements in drug formulation methods.
What Is Contributing to the Growth of the Head And Neck Squamous Cell Carcinoma Market?
The head and neck squamous cell carcinoma market growth is predicted to surge in line with escalating tobacco and alcohol use. Cultural influence, societal norms, stress levels, peer pressure, marketing strategies, and the availability of these substances contribute to their increasing consumption. Alcohol and tobacco use exacerbate the risk of head and neck squamous cell carcinoma (HNSCC) by promoting chronic irritation, DNA mutation, and reduced immunity, which together boosts carcinogenesis in the head and neck region. As per the Centers for Disease Control and Prevention, a government agency in the US, as of September 2024, tobacco use remains the foremost cause of preventable diseases and mortality in the country. In 2022, around 49.2 million adults, or 19.8%, stated they use tobacco products. Moreover, data from Digital, a UK-based National Health Service government division, in June 2024, indicate that in 2022, approximately 81% of adults had consumed alcohol within the past year. Men had a higher consumption rate (84%) than women (78%) during this period. As such, the escalating use of tobacco and alcohol is fuelling the head and neck squamous cell carcinoma market's expansion.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20826&type=smp
Which Key Market Leaders Are Driving Head And Neck Squamous Cell Carcinoma Industry Growth?
Major companies operating in the head and neck squamous cell carcinoma market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GSK plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Rakuten Medical Inc., Exelixis Inc., Akeso Inc., Fortress Biotech Inc., Hookipa Pharma Inc., MacroGenics Inc., Theriva Biologics Inc., Turnstone Biologics Inc., Nykode Therapeutics AS, Immutep Limited, Tizona Therapeutics Inc., Checkpoint Therapeutics Inc., Zenith Epigenetics Ltd.
What Are the Emerging Trends in the Head And Neck Squamous Cell Carcinoma Industry?
Prominent businesses in the head and neck squamous cell carcinoma space are turning towards strategic partnerships for the development of innovative combined treatments. These alliances in the head and neck squamous cell carcinoma sector allow companies to merge their resources and knowledge, speeding up research and development, while also boosting innovation. Such partnerships facilitate quicker commercialization by widening their market footprint and tapping into new demographics of patients. For example, in October 2024, US-based biotech firm Exelixis Inc. aligned with pharmaceutical giant Merck & Co. Inc., also from the US, to further cancer treatment solutions. The partnership's goal is to investigate the potential of combining zanzalintinib with KEYTRUDA and WELIREG in order to yield better patient outcomes for those suffering from head and neck squamous cell carcinoma (HNSCC) and renal cell carcinoma (RCC).
What Are the Main Segments in the Head And Neck Squamous Cell Carcinoma Market?
The head and neck squamous cell carcinoma market covered in this report is segmented -
1) By Type: Salivary Gland, Oral And Oropharyngeal, Nasal Cavity And Paranasal Sinuses, Nasopharyngeal, Laryngeal, Hypopharyngeal
2) By Drug Class: Epidermal Growth Factor Receptor (Egfr) Inhibitors, Immune Checkpoint Inhibitors, Other Drug Class
3) By Route Of Administration: Intravenous, Oral, Other Routes Of Administration
4) By Treatment: Radiation Therapy, Chemotherapy, Immunotherapy
5) By End-user: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Salivary Gland: Major Salivary Glands (Parotid, Submandibular), Minor Salivary Glands
2) By Oral And Oropharyngeal: Oral Cavity Cancer, Oropharyngeal Cancer (Tonsils, Base Of Tongue)
3) By Nasal Cavity And Paranasal Sinuses: Nasal Cavity Cancer, Paranasal Sinus Cancer
4) By Nasopharyngeal: Nasopharyngeal Carcinoma
5) By Laryngeal: Supraglottic Laryngeal Cancer, Glottic Laryngeal Cancer, Subglottic Laryngeal Cancer
6) By Hypopharyngeal: Hypopharyngeal Cancer
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/head-and-neck-squamous-cell-carcinoma-global-market-report
Which Geographic Area Leads the Head And Neck Squamous Cell Carcinoma Market?
North America was the largest region in the head and neck squamous cell carcinoma market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck squamous cell carcinoma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Head And Neck Squamous Cell Carcinoma Global Market Report?
- Market Size Analysis: Analyze the head and neck squamous cell carcinoma Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the head and neck squamous cell carcinoma Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall head and neck squamous cell carcinoma market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the head and neck squamous cell carcinoma market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20826
"
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Head And Neck Squamous Cell Carcinoma Market Projected to Surpass $2.81 Billion by 2029 with 9% Annual Growth here
News-ID: 3875627 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Carcinoma
Rising Occurrence Of Hepatocellular Carcinoma Fuels Growth In The Hepatocellular …
The Hepatocellular Carcinoma Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Hepatocellular Carcinoma Drugs Market Size During the Forecast Period?
The Hepatocellular Carcinoma Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025…
Major Market Shift in Urothelial Carcinoma Treatment Industry: Innovations In Ur …
What Is the Forecasted Market Size and Growth Rate for the Urothelial Carcinoma Treatment Market?
In the recent years, there has been a swift escalation in the size of the urothelial carcinoma treatment market. It is projected to expand from $2.86 billion in 2024 to $3.37 billion in 2025, boasting a Compound Annual Growth Rate (CAGR) of 18.0%. The growth during the past period can be credited to an upsurge in…
Hepatocellular Carcinoma Pipeline 2024
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the recent…
Urothelial Carcinoma Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Urothelial Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 40+ Urothelial Carcinoma companies and 50+ pipeline drugs in the Urothelial Carcinoma pipeline landscape. It covers the Urothelial Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Urothelial Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Urothelial Carcinoma Pipeline Insights Report 2024
DelveInsight's, "Urothelial Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 40+ Urothelial Carcinoma companies and 50+ pipeline drugs in the Urothelial Carcinoma pipeline landscape. It covers the Urothelial Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Urothelial Carcinoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Nasopharyngeal Carcinoma Treatment Market
The latest Report Available at USD Analytics Market, "Nasopharyngeal Carcinoma Treatment Market" provides a pin-point analysis of changing competitive dynamics and a forward-looking perspective on different factors driving or restraining industry growth.
As the Political, Economic, Social, Technological, Environmental, and Legal factors continue to change, business leaders across industries have shifted focus to strategic objectives to achieve market excellence. The "Global Nasopharyngeal Carcinoma Treatment Market Size, Share Analysis with Forecast to…
